PSilocybin for psYCHological and Existential Distress in PALliative Care (PSYCHED-PAL): A Multi-site, Open-label, Single Arm Phase I/II Proof-of-concept, Dose-finding, and Feasibility Clinical Trial
Phase: PHASE1, PHASE2 | Sponsor: Ottawa Hospital Research Institute | Compound: Psilocybin
- Status
- active
- Institution
- Ottawa Hospital Research Institute
- Start date
- 2024-01-08
- End date
- 2025-06-01
- Registry ID
- NCT04754061
Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.